Manufacturer
AstraZeneca Pharmaceuticals LP
Contents
Saxagliptin 5 mg, dapagliflozin 10 mg
Indication
Type 2 DM inadequately controlled on metformin alone or when already treated w/ fixed-dose combination in adults ≥18 yr.
Instruction
May be taken with or without food: Swallow whole.
Drug interaction
Increased risk of hypoglycaemia w/ insulin & insulin secretagogues eg, sulphonylureas. Loop diuretics; glucagon-like peptide 1; pioglitazone.
Malaysia
